Articles From: NeoGenomics Announces Closing of Recent Equity Offering and Exercise in Full of Underwriters' Over-Allotment Option to Neovasc Inc. Provides Additional Comments on Lawsuit


Seven Million Share Offering at $4.60 per Share FT.
Sign-up for NeoGenomics Announces Pricing of $32.2 Million Public Offering investment picks
FORT MYERS, Fla., Aug.
Sign-up for NeoGenomics Announces Public Offering of Common Stock investment picks
Adds Specialized Anatomic Pathology Services FORT MYERS, Fla.
Sign-up for NeoGenomics Completes Acquisition of Path Logic investment picks
Company Provides Widest Variety of Actionable Next-Gen Cancer Profiles FT.
Sign-up for NeoGenomics Expands Next Generation Sequencing Services and Offers 23 Different Profiles for Various Hematologic and Solid Cancers investment picks
Company Experiencing Strong Test Volume Growth FT.
Sign-up for NeoGenomics Raises Guidance and Projects 30% Year-Over-Year Revenue Growth in Quarter 2, 2014 investment picks
Company Raises Full-Year Revenue Guidance to $83 - $86 Million FT.
Sign-up for NeoGenomics Reports Record Revenues of $20.7 Million on 40% Test Volume Growth and Expanding Gross Margins for the Second Quarter 2014 investment picks
FT. MYERS, Fla., June 18, 2014 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO) announced today that it plans to release its second quarter 2014 financial results on Thursday July 17, 2014 .
Sign-up for NeoGenomics Schedules its Q2 2014 Earnings Release for July 17, 2014 investment picks
SANTA CLARA, Calif., June 26, 2014 (GLOBE NEWSWIRE) -- Neonode Inc., (Nasdaq:NEON) , the optical-touch technology licensing company, today officially launched zForce™AIR™, a breakthrough and game-changing technology which can touch enable any surface.
Sign-up for Neonode Launches zForce(TM)AIR(TM) Game Changing Technology -- Touch Enabling Any Surface investment picks
SANTA CLARA, Calif., July 23, 2014 (GLOBE NEWSWIRE) -- Neonode Inc. (Nasdaq:NEON) , the optical-touch technology licensing company, announced that it has started a collaboration with Magneti Marelli, a global Tier One automotive systems supplier, in the field of Human Machine Interfaces (HMIs) for the automotive sector.
Sign-up for Neonode(R) and Magneti Marelli to Jointly Develop Automotive HMI Solutions investment picks
SANTA CLARA, Calif., July 10, 2014 (GLOBE NEWSWIRE) -- Neonode Inc., (Nasdaq:NEON) , the optical-touch technology licensing company, announced that the US Patent and Trademark Office (USPTO) has recently issued Neonode patent #8,775,023 ('023) for Light-Based Touch Controls on a Steering Wheel and Dashboard.
Sign-up for Neonode(R) Issued US Patent for Light-Based Touch Controls on a Steering Wheel and Dashboard investment picks
SANTA CLARA, Calif., Aug.
Sign-up for Neonode(R) Issued US Patent for Touch-and-Glide Gesture investment picks
SANTA CLARA, Calif., Aug.
Sign-up for Neonode(R) Reports Results for Quarter Ended June 30, 2014 investment picks
SANTA CLARA, Calif., June 26, 2014 (GLOBE NEWSWIRE) -- Neonode Inc ., (Nasdaq:NEON) , the optical touch technology company is providing a summary of its recent market-update conference call, which was held on Monday, June 23, 2014.
Sign-up for Neonode(R) Summarizes Its Recent Conference Call investment picks
SANTA CLARA, Calif., June 19, 2014 (GLOBE NEWSWIRE) -- Neonode Inc ., (Nasdaq:NEON) , the optical touch technology company, announced today that it will host a conference call to update investors on the status of the business and to comment on the recent rumors and speculations about Neonode and the touchscreen market.
Sign-up for Neonode(R) to Host Investor Update Call investment picks
SANTA CLARA, Calif., July 29, 2014 (GLOBE NEWSWIRE) -- Neonode Inc ., (Nasdaq:NEON) , the optical touch technology company, announced today that it will release financial results for the three months ended June 30, 2014 on Wednesday August 6, 2014.
Sign-up for Neonode(R) to Report Second Quarter 2014 Results on August 6, 2014 investment picks
NeoPhotonics Corporation (NYSE: NPTN), a leading designer and manufacturer of photonic integrated circuits, or PIC, based optoelectronic modules and subsystems for bandwidth-intensive, high speed communications networks, today announced financial results for its second quarter ended June 30, 2014.
Sign-up for NeoPhotonics Reports Second Quarter Financial Results and Outlook for Third Quarter 2014 investment picks
NeoPhotonics Corporation (NYSE: NPTN), a leading designer and manufacturer of photonic integrated circuits, or PIC, based optoelectronic modules and subsystems for bandwidth-intensive, high speed communications networks, will report financial results for the second quarter ended June 30, 2014, after market close on Thursday, August 7, 2014.
Sign-up for NeoPhotonics to Host Conference Call to Discuss Second Quarter 2014 Financial Results on Thursday, August 7, 2014 investment picks
-- Preliminary Data Indicate Safety and Tolerability in Adult Patients and Complement Recently Published 12-Month Data Indicating Feasibility and Potential Efficacy in Children With T1DM --
Sign-up for NeoStem Announces UCSF Presentation of Phase 1 Results for T Regulatory Cell Immunotherapy for Type 1 Diabetes at American Diabetes Association Annual Meeting investment picks
NEW YORK, July 8, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) , a leader in the emerging cellular therapy industry, announced today the appointment of Steven M.
Sign-up for NeoStem Appoints Steven M. Klosk to Board of Directors investment picks
NEW YORK, July 14, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) , a leader in the emerging cellular therapy industry, announced today that Frost & Sullivan has awarded the Company its 2014 North American Cell Therapeutics Technology Innovation Leadership Award.
Sign-up for NeoStem Awarded 2014 Cell Therapeutics Technology Leadership Award from Frost & Sullivan investment picks
NEW YORK, June 23, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) , a leader in the emerging cellular therapy industry, announced today that it is set to join the broad-market Russell Global, Russell 3000, and Russell Microcap Indexes when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on Friday, June 27, 2014, according to a preliminary list of additions posted June 13 on www.russell.com/indexes .
Sign-up for NeoStem Set to Join Multiple Russell Indexes investment picks
NEW YORK, Aug.
Sign-up for NeoStem to Present at the Swedish-American Life Science Summit 2014 investment picks
NEW YORK, June 30, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) , a leader in the emerging cellular therapy industry, announced today that two of its leading cancer immunotherapy experts, Dr.
Sign-up for NeoStem's Cancer Immunotherapy Experts to Present at Novel Cancer Therapeutics Summit 2014 investment picks
NASDAQ: NVCN TSX VENTURE: NVC VANCOUVER , June 20, 2014 /PRNewswire/ - Neovasc Inc. (" Neovasc " or the " Company ") (NASDAQ: NVCN) (TSXV: NVC) today announced that effective at market opening on June 23, 2014 , Neovasc's common shares will commence trading on the Toronto Stock Exchange (the " TSX ") under the Company's current trading symbol of "NVC". "We are very pleased to announce another milestone for the Company and our shareholders.
Sign-up for Neovasc Inc. Announces Receipt of Final Approval to Graduate to the TSX investment picks
--Reports Year-over-Year Revenue Growth of 58%-- --Tiara's Successful First Use Cases Highlighted at Industry Conference--
Sign-up for Neovasc Inc. Announces Financial Results For The Second Quarter 2014 investment picks
Neovasc Inc. Provides Additional Comments on Lawsuit Canada NewsWire NASDAQ: NVCN TSX: NVC VANCOUVER , July 7, 2014 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) has today been made aware through a press release issued by CardiAQ Valve Technologies ("CVT") of a stay in proceedings in one of Neovasc's European patent applications based on a lawsuit filed by CVT against Neovasc in Germany .
Sign-up for Neovasc Inc. Provides Additional Comments on Lawsuit investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: NeoGenomics Announces Closing of Recent Equity Offering and Exercise in Full of Underwriters' Over-Allotment Option to Neovasc Inc. Provides Additional Comments on Lawsuit
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices